The correlation between the expression of DSG2 and the clinico-pathological characteristics most commonly associated with an aggressive prostate cancer phenotype, including serum Pre-surgical PSA concentration, Gleason Score, and Pathological Stage was then examined using Spearman's rank correlation (Table 3). The gene discussed is DSG2; the disease is Familial prostate cancer.